| id | Study | Lib. in paper | Exposition period | Study type  | 
                Control type  | 
                Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S9179 R31641  | 
                Shankaran (Phenobarbital) (Other indications), 2002 | Cerebral palsy (CP) (included diplegia, hemiplegia, triplegia, or quadriplegia) | days before delivery excluded | randomized controlled trial | unexposed, sick | Adjustment: Randomisation | 
                    0.73 [0.38;1.42] C  excluded (exposition period)  | 
                
                18/224 21/197 | 39 | 224 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9172 R31554  | 
                Van der Pol (Phenobarbital) (Controls unexposed, disease free), 1991 | Abnormal neurologic examination (neurologic handicap) | throughout pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No Matched | 
                    1.55 [0.06;40.54] C  excluded (control group)  | 
                
                0/12 1/55 | 1 | 12 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S9173 R31579  | 
                Van der Pol (Phenobarbital) (Controls unexposed, sick), 1991 | Abnormal neurologic examination (neurologic handicap) | throughout pregnancy | prospective cohort | unexposed, sick | Adjustment: No | 1.87 [0.03;100.54] C | 0/12 0/22 | 0 | 12 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1 studies | 1.87 [0.03;100.54] | 0 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Phenobarbital) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 9172